We are Sorry, This Page doesn't Exist
Moncef Slaoui is retreating from the biotech industry after facing a substantiated sexual-harassment claim
The complaint stems from Slaoui’s career at the pharma company GSK, which he left in 2017. He was later tapped to lead Trump’s vaccine effort. Moncef Slaoui, the former chief advisor t.....»»
AG James wants to ban "Pharma Bro" Shkreli for life from industry
Convicted ҠMartin Shkreli was sued by federal officials and the state of New York for allegedly when he jacked up the price of a crucial drug by 4,000% overnight in 2015. The lawsuit was filed... To view the full story, click the title link......»»
The 2010s were a decade of drug breakthroughs
For all the flak the pharmaceutical industry has taken for its exorbitant pricing practices, there's no getting around the fact that it'.....»»
Capitol Report: Pelosi’s drug-pricing bill passes House, but pharma stocks are up as it’s unlikely to become law
The Democratic-led House on Thursday passes the party’s signature bill that aims to lower drug prices, as Democrats continue to make an effort to show that they’re not solely focused on impeaching President Donald Trump......»»
Capitol Report: Pelosi’s drug-pricing bill set to pass House on Thursday, but pharma stocks are up as it’s unlikely to become law
Top Democratic lawmakers say Thursday that the House in the coming days will pass their signature bill that aims to lower drug prices, as they make an effort to show that they’re not solely focused on impeaching President Donald Trump......»»
LabCentral co-founder issues ‘call to action" to biotechs on drug pricing
LabCentral co-founder and industry veteran Johannes Fruehauf .....»»
How Big Pharma plays games with drug patents and how to combat it
Drug companies overcharge in ways that are unique to their industry. America's patent system should reward innovation, not.....»»
What the $63 Billion AbbVie Allergan Deal Says About the Drug Industry: Brainstorm Health
AbbVie's acquisition of the Botox maker isn't a great reflection on the state of big pharma innovation. Good afternoon, readers. Let’s parse the.....»»
Abbvie To Buy Allergan For $60 Billion In Latest Pharma Megadeal
Just months after Bristol-Myers Squibb and Celgene announced one of the biggest drug industry tie-ups in recent memory.....»»
Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries
Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices in other countries would face legal challenges if adopted......»»
Pharmas Acknowledge Drug Pricing Controversies As A Business Risk
In Response To Shareholder Pressure, Pharma Companies Begin To Acknowledge Drug Pricing Controversies As A Business Risk Second-year shareholder resolutions highligh.....»»
Lannett: Industry-Wide Drug Pricing Case Enters The Criminal Phase
Lannett: Industry-Wide Drug Pricing Case Enters The Criminal Phase.....»»
"Pharma bro" continues to run drug company from behind bars
Behind bars in Fort Dix, N.J., pharmaceutical executive Martin Shkreli is still calling the shots at Phoenixus AG, using a contraband smartphone.A few weeks ago, Shkreli called a chief executive that... To view the full story, click the title link......»»
"Pharma Bro" moves to New Jersey for federal prison stay
The pharmaceutical-industry entrepreneur vilified for jacking up the price of a life-saving drug was moved Tuesday to a low-security federal prison in New Jersey. Martin Shkreli was sent from the... To view the full story, click the title link......»»
"Pharma Bro" arrives at low-security federal prison
The pharmaceutical-industry entrepreneur vilified for jacking up the price of a life-saving drug has been placed in a low-security federal prison in New Jersey......»»
Johnson & Johnson Raises Sales Outlook
Johnson & Johnson reported higher-than-expected sales in its latest quarter and boosted its sales outlook for the year despite ongoing pricing pressures in the drug industry......»»
Drug/Biotech Q1 Earnings Lineup on May 8: JAZZ, ARNA & More
The pharma/biotech industry has witnessed a mixed first-quarter earnings picture so far. Let's see what's in store for some of the smaller players. The first-quarter earnings season has been relatively stro.....»»
Drug Prices Too High? Don’t Blame Rebates. Blame the FDA Approval Process
Both biotech and pharma may soon come under a pricing attack, and it could endanger future research initiatives and the flow of new drugs to marketRelated Stocks: ESRX, VRTX,.....»»
Breakingviews TV - Trump drug dump
The president has unveiled long-promised plans to bring down the price of prescription medication. Antony Currie and Robert Cyran explain how it’s far more of a sop to the pharma industry than a salve for overcharged consumers......»»
Novartis hints at 2018 outlook hike despite drug price freeze
Novartis may ratchet up its 2018 sales outlook, its finance chief said on Wednesday, despite halting planned U.S. drug price hikes amid pressure on the industry from President Donald Trump's administration over the high cost of medicines......»»